UiPath PATH saw its IBD SmartSelect Composite Rating rise to 96 Wednesday, up from 94 the day before. Please watch the video ...

UiPath (PATH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish. As you can see from the chart above the ...

Small- and mid-cap AI plays - PATH, FIVN, QLYS, TDC and BB lagged last year but could become game changers in 2026 as AI infrastructure demand stays bullish.

UiPath could become the connective tissue linking the software sprawl that companies face. AI is helping UiPath expand the boundaries of traditional robotic process automation. Its focus on secure, ...

UiPath presents a compelling accumulation opportunity after recent profit-taking, with core RPA business strength and visible AI-driven growth catalysts. PATH's revenue growth has stabilized at double ...

I recommend rotating into catalyst-driven small- and mid-cap stocks like UiPath to protect capital as the S&P 500 hits new highs. UiPath stands out with improving sales momentum, profitability, and a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

A rush of agentic AI solutions is hitting the enterprise market, and now one of the bigger players in automation has scooped up a startup in the space in hopes of taking a bigger piece of that market.